The Minister for Health, Simon Harris, is going to hold talks with British health secretary Jeremy Hunt on the cystic fibrosis drug Orkambi this week as negotiations between the HSE and the drug’s manufacturer restart.
The HSE’s drugs committee had decided that Orkambi does not deliver enough benefit to patients to justify the €159,000 per patient, per year that its manufacturer, Vertex, has sought. But the HSE will restart negotiations with the makers...
Subscribe from just €1 for the first month!
All Digital Access + eReader
Unlimited Access for 1 Month
Then €19.99 a month after the offer period.
€149 For the 1st Year
Unlimited Access for 1 Year
90 Day Pass
Get a Business Account for you and your team